Information Provided By:
Fly News Breaks for September 19, 2018
WMGI
Sep 19, 2018 | 09:27 EDT
Stifel analyst Mathew Blackman said his survey of 51 U.S. foot and ankle surgeons was "highly encouraging" for Wright Medical and increase his confidence in the outlook for accelerating AUGMENT growth. The analyst, who continues to believe Wright Medical shares are undervalued, keeps a Buy rating and $34 price target on the stock following the survey.
News For WMGI From the Last 2 Days
There are no results for your query WMGI